Celularity Inc. Unrealized Gain (Loss) on Securities
Celularity Inc. (CELU) reported Unrealized Gain (Loss) on Securities of $2.24 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnSecurities · last filed 2021-05-24
- Celularity Inc. unrealized gain (loss) on securities for the quarter ending 2020-12-31 was -$16.24K.
- Celularity Inc. unrealized gain (loss) on securities for the quarter ending 2020-09-30 was $60.09K.
- Celularity Inc. unrealized gain (loss) on securities for the quarter ending 2020-06-30 was -$471.50K, a 291.21% decline year-over-year.
- Celularity Inc. unrealized gain (loss) on securities for the quarter ending 2020-03-31 was $429.89K.
- Celularity Inc. unrealized gain (loss) on securities for fiscal 2020 was $2.24K.
- Celularity Inc. unrealized gain (loss) on securities for fiscal 2019 was -$7.87K.
| Period end | Unrealized Gain (Loss) on Securities 3 month | Unrealized Gain (Loss) on Securities 6 month | Unrealized Gain (Loss) on Securities 9 month | Unrealized Gain (Loss) on Securities 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$16.24K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $43.85K derived: sum of 2 quarters · filed 2021-05-24 | -$427.65K derived: sum of 3 quarters · filed 2021-05-24 | $2.24K 10-K/A · filed 2021-05-24 |
| 2020-09-30 | $60.09K 10-Q · filed 2020-11-16 | -$411.41K derived: sum of 2 quarters · filed 2020-11-16 | $18.48K 10-Q · filed 2020-11-16 | -$177.32K derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-06-30 | -$471.50K 10-Q · filed 2020-08-13 | -$41.61K 10-Q · filed 2020-08-13 | -$237.41K derived: sum of 3 quarters · filed 2021-05-24 | -$296.07K derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-03-31 | $429.89K 10-Q · filed 2021-05-24 | $234.09K derived: sum of 2 quarters · filed 2021-05-24 | $175.43K derived: sum of 3 quarters · filed 2021-05-24 | $422.02K derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | -$195.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$254.46K derived: sum of 2 quarters · filed 2021-05-24 | -$7.87K derived: sum of 3 quarters · filed 2021-05-24 | -$7.87K 10-K/A · filed 2021-05-24 |
| 2019-09-30 | -$58.66K 10-Q · filed 2020-11-16 | $187.93K derived: sum of 2 quarters · filed 2020-11-16 | $187.93K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $246.59K 10-Q · filed 2020-08-13 | $246.59K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |